Names and pronunciation
(ax-i-cab′tay-jeen-sye-lo′loo-sel) Yescarta
PDF page 131
Loading InternPractice…
Drug reference
(ax-i-cab′tay-jeen-sye-lo′loo-sel) Yescarta
PDF page 131
Func. class.: Antineoplastic, cellular immunotherapies
PDF page 131
USES: For the treatment of non- Hodgkin’s lymphoma
PDF page 131
CONTRAINDICATIONS: Hyper sensitivity
PDF page 131
Black Box Warning: Cytokine release syn- drome
PDF page 131
DOSAGE AND ROUTES Large B-cell lymphoma • Adult: IV 2 × 106 CAR-positive viable T cells per kg of body weight (max dose of 2 × 108 CAR-positive viable T cells) as a single IV dose Therapeutic drug monitoring: management of treatment-related toxicity; refer to package insert
PDF page 131
Available forms: Infusion bag: 2 × 106 chimeric antigen receptor–positive T cells/kg A HIGH ALERT
PDF page 131
• Adult: IV 2 × 106 CAR-positive viable T cells per kg of body weight (max dose of 2 × 108 CAR-positive viable T cells) as a single IV dose Therapeutic drug monitoring: management of treatment-related toxicity; refer to package insert
PDF page 131